We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA investigators increasingly are shifting from “top down” inspections focused on policies to “bottom up” inspections that focus on raw data, an industry insider says. Read More
Revisions to the FDA’s Regulatory Procedures Manual don’t add any clarity on when a product removal is a recall and when it’s a market withdrawal, attorneys say. Read More